Cargando…
Posaconazole-Induced Hypertension Due to Inhibition of 11β-Hydroxylase and 11β-Hydroxysteroid Dehydrogenase 2
We describe two cases of hypertension and hypokalemia due to mineralocorticoid excess caused by posaconazole treatment of coccidioidomycosis and rhinocerebral mucormycosis infections, respectively. Clinical laboratory evaluations, including a comprehensive analysis of blood and urine steroid profile...
Autores principales: | Thompson, George R, Beck, Katharina R, Patt, Melanie, Kratschmar, Denise V, Odermatt, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6608555/ https://www.ncbi.nlm.nih.gov/pubmed/31286100 http://dx.doi.org/10.1210/js.2019-00189 |
Ejemplares similares
-
11β-Hydroxysteroid dehydrogenases control access of 7β,27-dihydroxycholesterol to retinoid-related orphan receptor γ
por: Beck, Katharina R., et al.
Publicado: (2019) -
Posaconazole-induced hypertension and hypokalemia due to inhibition of the 11β-hydroxylase enzyme
por: Barton, Kevin, et al.
Publicado: (2018) -
The ratio of ursodeoxycholyltaurine to 7‐oxolithocholyltaurine serves as a biomarker of decreased 11β‐hydroxysteroid dehydrogenase 1 activity in mouse
por: Weingartner, Michael, et al.
Publicado: (2021) -
11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome
por: Bailey, Matthew A.
Publicado: (2017) -
Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases
por: Markey, Keira A, et al.
Publicado: (2016)